Skip to main content
Journal cover image

Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter.

Publication ,  Journal Article
Almani, MU; Talha, KM; Khan, LA; Hameed, I; Asad, ZUA; Fudim, M; Krasuski, R; Khan, MS
Published in: Am J Cardiol
July 1, 2024

Atrial fibrillation/flutter (AF) is the most common dysrhythmia in patients with hypertrophic cardiomyopathy (HCM). Unexplained left ventricular hypertrophy and left ventricular outflow tract obstruction are integral components of HCM pathology which can cause increased left atrial pressure and atrial myopathy contributing to the substrate for AF. We aimed to determine the impact of AF on hospital readmissions in patients with HCM. We conducted a retrospective analysis using the 2015 to 2019 Nationwide Readmission Database to analyze the effect of AF on 30-day readmission and causes of 30-day readmission in patients with HCM. We also determined the hospital, patient, and procedure-specific independent predictors of readmission in patients with HCM and AF. Of 191,235 index HCM hospitalizations, 81,390 (42.6%) had a secondary diagnosis of AF. A total of 16.9% of patients with HCM and AF were readmitted within 30 days as compared with 14% of HCM patients without AF. The presence of AF was independently associated with a higher risk of all-cause 30-day readmission (hazard ratio [HR] 1.21, 95% confidence interval [CI] 1.17 to 1.25, p <0.001). The foremost etiology of 30-day readmission in HCM patients with AF was hypertensive heart and chronic kidney disease with heart failure, whereas the foremost etiology of 30-day readmission in HCM patients without AF was sepsis. Interventions aimed toward AF management (electrical cardioversion: adjusted HR 0.91, 95% CI 0.82 to 1.01. p = 0.074, AF ablation: HR 0.92, 95% CI 0.74 to 1.13, p = 0.409, Watchman procedure: HR 1.50, 95% CI 0.16 to 14.6, p = 0.725) during index admission did not significantly impact the 30-day readmission in HCM patients with AF. Myectomy during index hospitalization (adjusted HR 0.54, 95% CI 0.34 to 0.86, p = 0.010) was most strongly associated with a lower risk of 30-day readmission in HCM patients with AF. In conclusion, in patients hospitalized for HCM, presence of AF was associated with excess risk of 30-day all-cause readmission. Interventions aimed toward HCM management, that is, myectomy rather than interventions aimed toward AF management predicted lower readmission rate in this patient population.

Duke Scholars

Published In

Am J Cardiol

DOI

EISSN

1879-1913

Publication Date

July 1, 2024

Volume

222

Start / End Page

29 / 34

Location

United States

Related Subject Headings

  • United States
  • Risk Factors
  • Retrospective Studies
  • Prevalence
  • Patient Readmission
  • Middle Aged
  • Male
  • Humans
  • Female
  • Cardiovascular System & Hematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Almani, M. U., Talha, K. M., Khan, L. A., Hameed, I., Asad, Z. U. A., Fudim, M., … Khan, M. S. (2024). Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter. Am J Cardiol, 222, 29–34. https://doi.org/10.1016/j.amjcard.2024.04.009
Almani, Muhammad Usman, Khawaja Muhammad Talha, Laibah Arhsad Khan, Ishaque Hameed, Zain Ul Abideen Asad, Marat Fudim, Richard Krasuski, and Muhammad Shahzeb Khan. “Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter.Am J Cardiol 222 (July 1, 2024): 29–34. https://doi.org/10.1016/j.amjcard.2024.04.009.
Almani MU, Talha KM, Khan LA, Hameed I, Asad ZUA, Fudim M, et al. Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter. Am J Cardiol. 2024 Jul 1;222:29–34.
Almani, Muhammad Usman, et al. “Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter.Am J Cardiol, vol. 222, July 2024, pp. 29–34. Pubmed, doi:10.1016/j.amjcard.2024.04.009.
Almani MU, Talha KM, Khan LA, Hameed I, Asad ZUA, Fudim M, Krasuski R, Khan MS. Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter. Am J Cardiol. 2024 Jul 1;222:29–34.
Journal cover image

Published In

Am J Cardiol

DOI

EISSN

1879-1913

Publication Date

July 1, 2024

Volume

222

Start / End Page

29 / 34

Location

United States

Related Subject Headings

  • United States
  • Risk Factors
  • Retrospective Studies
  • Prevalence
  • Patient Readmission
  • Middle Aged
  • Male
  • Humans
  • Female
  • Cardiovascular System & Hematology